Author Archive: Jeremy Parkinson
Chinese Inquiries On U.S. Real Estate Soar 35% After Easing Of Visa Rules
In a nation in which 1 out of every 3 homes is unaffordable, you’d think the primary goal of public policy wouldn’t be to ensure real estate becomes even more out of reach for the average citizen. However, we live in a country in which policy isn’t being driven by logic and what’s in the best interest of “the people,” rather, we live in […]
EC Surprise: Speculators Are Long Oil
Oil prices have declined for the better part of the past five months. The unexpected contraction in the Japanese economy in Q3 underscores that the strong supply growth is taking place amid weakening demand. OPEC’s meeting is still ten days away. Remember that OPEC oil is mostly the heavy sour variety, while the US shale product […]
E Inovio Discloses Deal Break-up Over Prostate Cancer Deal – Roche To Still Collaborate On Hepatitis B Vaccine
Shares of Inovio Pharmaceuticals (INO) tumbled around 10% today on the news that the Roche deal with Inovio’s Prostate cancer vaccine, known as INO-5150, is being dropped. Both Inovio and Roche were to collaborate on INO-5150 and Roche was going to help fund the pre-clinical costs and other clinical expenses. The reason for the termination […]
Time For A Gold/Silver ETF
Does a rising ratio foretell a reversion? I can’t believe nobody’s done this before. I mean putting out a gold/silver ratio ETF. During the recent precious metals swoon, it would have been a real money maker. While gold and silver tumbled from their lofty heights over the past 3½ years, the ratio’s risen to near […]
EC Investors Make Up New Rules For Their New Market Paradigm
Investors in U.S. equities seem to have embraced a new market paradigm in which upside spikes come more swiftly than the downside selloffs. Remember when it used to be the other way around? When fear was stronger than greed? The market is consolidating its gains off the early-October V-bottom reversal, and no one seems to be in […]
Market Commentary: Markets In The Red, Eventual Session Direction In Doubt
Written by Gary Averages slipped back into the red after a brief moment in the green peaking around 10 am. This time the volume was mostly red and heavy as some investors took their profits. By 12 noon the decent sea-sawed, rising giving brief hope the averages were moving up again only to fall further. The […]
Actavis Purchase Of Allergan Makes It A “$100 Billion Merger Monday”
This may not quite be the blow-off top in the merger bubble as companies rush to frontrun the ECB and buy whatever still isn’t nailed, but it is getting close. Because while earlier today Baker Hughes announced it would accept the Halliburton offer to buy it unchallenged in a $35 billion transaction leading many to […]
Gold Peeks Above Resistance
A Surprise Move on Friday Shortly after we posted our most recent comment on gold sentiment on Thursday evening after the NY market close, the precious metals once again tanked overnight in Asian trading. To our surprise, the move was reversed rather spectacularly later at the COMEX, with gold producing a bullish engulfing candle on the day. […]
FeeX: The Robin Hood Of (Investment) Fees
Investment fees can literally suck hundreds of thousands of dollars out of your retirement accounts over your lifetime. What makes this even more aggravating is that as investors, we aren’t even aware of some of the fees we pay because fund managers have gone through such lengths to obfuscate them. FeeX bills itself as the […]
Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Update November 18 : NASDAQ 4702 up 0.67%, IBB at 295.25up 2.22% Recent Small Cap picks: CLDX 17.72 off 2.9% with profit taking.Very choppy trade. FCSC 2.67 flat little action, despite Press Release on amputee treatment. Foundation Medicine (FMI) at $25.86 up 2.67%. DNA tests for genetic profiling of potential cancer treatments. KPTI $40.71 flat . Phase […]
